Search research articles
Contact Us
Filters
Showing results (91-100 of 144) with videos related to
Page
of 15
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
November 23, 2021
Metastatic progression following multimodal therapy for unfavorable-risk prostate cancer
David Guy, Rachel Glicksman, Roger Buckley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 29, 2021
Elective pelvic nodal irradiation with a simultaneous hypofractionated integrated prostate boost for localized high risk prostate cancer: Long term results from a prospective clinical trial
Rachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 3, 2018
Phase 1-2 Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation in Patients With High-Risk Prostate Cancer (SATURN): Early Toxicity and Quality of Life
Hima Bindu Musunuru, Laura D'Alimonte, Melanie Davidson, et al.
JAMA Oncology
|
June 13, 2024
Stereotactic Ablative Radiotherapy for Gynecological Oligometastatic and Oligoprogessive Tumors
Elysia K Donovan, Simon S Lo, Sushil Beriwal, et al.
Practical Radiation Oncology
|
July 4, 2021
Organ at Risk Dose Constraints in SABR: A Systematic Review of Active Clinical Trials
Serenna G Gerhard, David A Palma, Andrew J Arifin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 15, 2024
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy: A 9-year update
John M Hudson, Andrew Loblaw, Merrylee McGuffin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 29, 2018
Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials
Yasir Alayed, Patrick Cheung, Geordi Pang, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
August 17, 2016
Developing and Evaluating Multimedia Patient Education Tools to Better Prepare Prostate-Cancer Patients for Radiotherapy Treatment (Randomized Study)
Krista Dawdy, Katija Bonin, Steve Russell, et al.
Technology in Cancer Research & Treatment
|
September 10, 2015
Computed Tomography Evaluation of Density Following Stereotactic Body Radiation Therapy of Nonspine Bone Metastases
Rachel McDonald, Linda Probyn, Ian Poon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 5, 2015
Tumor Response After Stereotactic Body Radiation Therapy to Nonspine Bone Metastases: An Evaluation of Response Criteria
Rachel McDonald, Linda Probyn, Ian Poon, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 144) with videos related to
Sort By:
Page
of 15
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
November 23, 2021
Metastatic progression following multimodal therapy for unfavorable-risk prostate cancer
David Guy, Rachel Glicksman, Roger Buckley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 29, 2021
Elective pelvic nodal irradiation with a simultaneous hypofractionated integrated prostate boost for localized high risk prostate cancer: Long term results from a prospective clinical trial
Rachel M Glicksman, Andrew Loblaw, Gerard Morton, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 3, 2018
Phase 1-2 Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation in Patients With High-Risk Prostate Cancer (SATURN): Early Toxicity and Quality of Life
Hima Bindu Musunuru, Laura D'Alimonte, Melanie Davidson, et al.
JAMA Oncology
|
June 13, 2024
Stereotactic Ablative Radiotherapy for Gynecological Oligometastatic and Oligoprogessive Tumors
Elysia K Donovan, Simon S Lo, Sushil Beriwal, et al.
Practical Radiation Oncology
|
July 4, 2021
Organ at Risk Dose Constraints in SABR: A Systematic Review of Active Clinical Trials
Serenna G Gerhard, David A Palma, Andrew J Arifin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 15, 2024
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy: A 9-year update
John M Hudson, Andrew Loblaw, Merrylee McGuffin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 29, 2018
Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials
Yasir Alayed, Patrick Cheung, Geordi Pang, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
August 17, 2016
Developing and Evaluating Multimedia Patient Education Tools to Better Prepare Prostate-Cancer Patients for Radiotherapy Treatment (Randomized Study)
Krista Dawdy, Katija Bonin, Steve Russell, et al.
Technology in Cancer Research & Treatment
|
September 10, 2015
Computed Tomography Evaluation of Density Following Stereotactic Body Radiation Therapy of Nonspine Bone Metastases
Rachel McDonald, Linda Probyn, Ian Poon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 5, 2015
Tumor Response After Stereotactic Body Radiation Therapy to Nonspine Bone Metastases: An Evaluation of Response Criteria
Rachel McDonald, Linda Probyn, Ian Poon, et al.
Page
of 15